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doi:10.1016/j.jtcvs.2004.01.015TBackground: Reducing the negative side effects associated with extracorporeal
circulation is the major advantage of off-pump revascularization. However, side
clamping of a calcified aorta for proximal anastomoses can cause emboli, resulting
in neurologic damage. This problem has been addressed by introducing a mechan-
ical anastomosis device (Symmetry, St Jude Medical) that allows vein-to-aorta
anastomosis without manipulating the aorta. This report describes our experience
with this device.
Methods: Between June 2001 and April 2002, 77 connectors (1.3 per patient) were
deployed in 61 patients (51 men and 10 women; mean age, 68  8.6 years)
undergoing off-pump coronary artery bypass grafting or beating-heart revascular-
ization. Intraoperative quality assessment included transit-time flow measurement
(Medistim) and indocyanine green–based angiography (Spy, Novadaq).
Results: The surgeons were meticulously trained in loading of the device. No
postoperative neurologic deficits were detected. Fifty-three patients had an unevent-
ful course. However, 8 (13.1%) patients with 12 implanted connectors were symp-
tomatic within 8 months (1 day to 8 months). Angiography revealed significant
(95%) stenosis or even occlusion of the proximal vein-to-aorta anastomosis at the
level of all connectors. Four patients underwent reoperation (2 dilated-stented and
2 treated with drugs).
Conclusion: On the basis of these observations, the routine use of the connector was
halted at our institution. At the moment, the use of this therapy is reserved for
patients with severely calcified aortas with no technical alternative. Further inves-
tigations appear necessary to evaluate the clinical patterns of this otherwise prom-
ising technology.
Over the last years, off-pump coronary artery bypass (OPCAB) andminimally invasive cardiac surgery have been progressively per-formed. Especially in the elderly, the reduced morbidity andmortality of OPCAB surgery appears to be related to the avoid-ance of the negative pathophysiologic effects of extracorporealcirculation.1 In addition to the elimination of the complex sys-
temic inflammatory response during and after extracorporeal circulation, a major
concern with OPCAB surgery remains the manipulation of the ascending aorta, with
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risk of neurologic complications.
Recently, the Symmetry Aortic Connector System
(SACS; St Jude Medical, Inc, Minneapolis, Minn) was
introduced as a mechanical device to perform proximal vein
graft anastomosis without the need for side clamping the
aorta. With the first clinical testing of the SACS in early
2001, several groups reported its successful application in
OPCAB surgery.2
Since June 2001, the SACS was routinely used in
OPCAB surgery (less in beating-heart procedures) in our
institution. The deployment was indicated when trans-
esophageal echocardiography revealed calcification of
the ascending aorta of grade II or more, digital examina-
tion of the ascending aorta showed severe calcification,
or mean arterial pressure of less than 60 mm Hg could not
be medically achieved for low-risk side clamping. The
surgeons were meticulously trained in the mounting and
deployment of the device before intraoperative applica-
TABLE 1. Summarized data of presented cases
Patient
no.
Age/
sex
Primary
procedure
Performed
bypasses
Affected graft a
level of conne
1 57 y/M OPCAB LITA-LAD-D V-RCA (o)
RITA-intermedius
V-RCA
2 76 y/M Beating
heart
LITA-LAD
V1-RCA
V2-intermedius
V1-RCA (s, 95
V2-intermediu
3 67 y/M OPCAB LITA-LAD
V1-RCA
V2-D-OM-Cx
V1-RCA (s, 95
V2-D-OM-Cx (s,
4 58 y/M OPCAB LITA-LAD
V1-RIVP-RCA
V2-intermedius-
OM
V1-RIVP-RCA
V2-intermedius
(s, 80%)
5 64 y/F OPCAB LITA-LAD V-D (o)
V-D Dissected LITA
6 81 y/F Beating
heart
V1-OM1-OM2
V2-LAD-D-
V3-PDA (o
Intermedius
V3-PDA
7 70 y/M OPCAB RITA-RCA
LITA-LAD
V-D-Cx
V1-D-Cx (o
8 66 y/M OPCAB RITA-RCA
V-Cx
LITA-LAD
(implanted in V)
V-Cx (s, 99%
LITA, Left internal thoracic artery; LAD, left anterior descending coronary
RCA, right coronary artery; o, occluded; s, stenotic; PTCA, percutaneous
circumflex coronary artery; CABG, coronary artery bypass grafting; PDA, ption, and consequently, we rarely encountered any severe
1422 The Journal of Thoracic and Cardiovascular Surgery ● Maintraoperative malfunctions of the connector. Handling of
the SACS is uncomplicated, and deployment time is
reasonable. After loading the vein segment on the device,
a hole is cut into the ascending aorta with the St Jude
Medical cutter. Subsequently, the device is introduced,
and the vein graft is fixed to the aortic wall with the
Nitinol-based connector. Because of the perpendicular
implantation of the vein segment to the aorta, it is crucial
to determine the correct position to avoid any potential
angulation and kinking of the bypass graft with subse-
quent early occlusion. Hence graft flow was routinely
assessed by using a transit-time flow probe (Medistim,
Norway) or the indocyanine green– based SPY system
(Novadaq, Canada) after each anastomosis and before
sternal closure.
Despite these measurements, we encountered several dif-
ficulties after the use of the connector system. We not only
observed intraoperative malfunction but also, more impor-
tantly, early postoperative complications necessitating sev-
Time to clinical
symptoms/diagnosis Type of reintervention
Antiplatelet
Therapy
Figure
no.
4 d None Aspirin 1
5 wk PTCA and stenting of
RCA at level of
connector
Aspirin 2
)
5 mo PTCA of V1-RCA and
PTCA and stenting of
V2-D-OM-Cx at level
of connector
Aspirin 3
6 mo None (patient
refused)
Aspirin 4
3 d CABG (V-D-LAD) Aspirin 5
7 d OPCAB (LITA-V2) Aspirin 
Plavix
6
Intraoperative Reimplantation
V1-D-Cx
Aspirin 
Plavix
8 mo Reoperation
V-Cx-LAD
Aspirin 
Plavix
7
; D, diagonal coronary artery; RITA, right internal thoracic artery; V, vein;
luminal coronary angioplasty; OM, obtuse marginal coronary artery; Cx,
ior descending coronary artery; OPCAB, off-pump coronary artery bypass.t the
ctor
%)
s (o)
%)
95%
(o)
-OM
-LAD
)
)
)
artery
trans
ostereral emergency reinterventions. Given the relatively high
y 2004
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ETincidence of these complications, we decided to summarize
and present these complicated cases to stipulate a discussion
regarding the routine application of connecting devices.
Case Reports
A brief summary of data is depicted in Table 1. Angiograms and
further information are depicted in the corresponding figures (Fig-
Figure 1. Angiogram revealing occlusion of a vein graft to the
right coronary artery at the level of the device (circle).
Figure 2. Angiogram revealing occlusion of a vein graft to the
intermediate branch at the level of the device (circle).ures 1-7).
The Journal of ThoracicDiscussion
OPCAB surgery achieved increasing acceptance as an al-
ternative to conventional coronary artery revascularization
Figure 3. Angiogram revealing 95% stenosis of a vein graft to the
diagonal coronary artery– obtuse marginal coronary artery– cir-
cumflex artery at the level of the device (circle).
Figure 4. Angiogram revealing 80% stenosis of a vein graft to the
intermediate branch– obtuse marginal coronary artery at the level
of the device (circle).and its complications after cardiopulmonary bypass and
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tractor and stabilization systems and exposure techniques,
multivessel OPCAB is feasible in the majority of cases.
Several studies have shown a decreased operative mortality
Figure 5. Angiogram revealing occlusion of a vein graft to the
diagonal coronary artery at the level of the device (circle).
Figure 6. Angiogram revealing occlusion of a vein graft to the
posterior descending coronary artery. When pushing the catheter
through the device, bypass could be exposed (circle).and postoperative morbidity, decreased intensive care unit
1424 The Journal of Thoracic and Cardiovascular Surgery ● Maand hospital stay, and reduced costs.3,4 OPCAB appears to
be an especially attractive approach in the management of
patients with a heavily calcified aorta. The prevention of
neurologic problems after coronary artery revascularization
represents a complex and multifaceted issue; however, a
major contributing factor is the avoidance of manipulations
of the aorta.
With the recent introduction of automated sutureless
anastomotic devices, it is possible to eliminate aortic ma-
nipulation and to avoid crossclamping of the aorta. The St
Jude Symmetry aortic connector system has gained increas-
ing popularity as a mechanical anastomotic device by facil-
itating proximal vein-graft-to-aorta anastomoses. Several
groups performed initial studies evaluating the safety and
efficacy of the new mechanical anastomotic device. Verma
and colleagues5 showed no difference between saphenous
vein graft segments after loading and deployment by using
the aortic connector system compared with conventional
techniques. A study by Eckstein and associates2 demon-
strated the safe and reliable application of the aortic con-
nector system in 20 consecutive OPCAB procedures. How-
ever, all patients had only a 3-month follow-up that
demonstrated no cardiac-related events. In contrast, a re-
view by Hornik and coworkers6 in 45 patients receiving 69
aortic connector devices during OPCAB and on-pump pro-
cedures with a follow-up of several weeks revealed stenosed
grafts in 4 patients, requiring percutaneous transluminal
coronary angioplasty (PTCA) or redo operations.
The present report showed comparable findings. The
Figure 7. Angiogram revealing 99% stenosis of a vein graft to the
circumflex coronary artery at the level of the device (circle).connector system was used in 61 patients during OPCAB
y 2004
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routine follow-up by the cardiologic referral centers of our
institution. Seventy-seven aortic connectors (1.3 per patient)
were deployed. After a mean follow-up of 88 days (1 day to
8 months), 8 patients demonstrated stenosed or occluded
vein grafts. The situation was individually managed with
reoperation in 4 patients, PTCA in 1 patient, and PTCA with
subsequent stent implantation in 1 patient. Two patients
refused any further intervention. All patients were undergo-
ing antiplatelet therapy, consisting of 100 mg of aspirin
alone (n  5), and beginning in 2002, a daily dosage of 75
mg of clopidrogrel bisulfate (Plavix; Sanofi-Synthelab,
Paris, France) (n  3) was added to this regimen. The
regimen has been changed for all coronary artery bypass
grafting operations, regardless of the technique used for
revascularization.
The total observed restenosis-occlusion rate of 15.6% of
connectors is comparable with the findings of Fitzgibbon
and associates,7 who reported an occlusion rate of 12% for
handsewn vein grafts within the first postoperative year.
Antiplatelet therapy consisted of aspirin and dipyridamole
in this study. However, graft fate was primarily the result of
distal anastomotic irregularities.
Reviewing our patients who had undergone revascular-
ization in the same time period without the use of proximal
connectors but with conventionally hand-sewn proximal
anastomoses, none had to undergo reoperation because of
proximal stenosis or occlusion of the graft.
In contrast to the comparable rate of restenosis, we
observed the occurrence of stenosis-occlusion of the me-
chanically anastomosed bypass grafts at an early time point
postoperatively. All patients were re-examined because of
dyspnea, chest pain, or electrocardiographic changes, in-
crease of enzyme levels, or both. Furthermore, angiographic
and intraoperative findings located the restenosis-occlusion
at the level of the device, whereas the location of sponta-
neous restenosis of saphenous bypass grafts is described to
be located at the distal part of the anastomosis. Regarding
timing and location of the stenosis process, a potential
involvement of the device has to be taken into consider-
ation.
The proximal vein–aorta anastomosis is performed by
using a connector that is exposed to the blood flow on the
edge of the aortic puncture side over a length of several
millimeters along the intimal layer of the vein graft. The
connector consists of Nitinol, an alloy of nickel titanium
that shows favorable mechanical and physiochemical prop-
erties. Nitinol is already used in a variety of medical de-
vices, such as vena cava filters and self-expanding coronary
stents. In vivo studies demonstrated favorable patency rates
for implanted Nitinol stents. Sutton and coworkers8 im-
planted 12 Nitinol stents with an internal diameter of 5 mm
into the iliac and femoral arteries of dogs for 2 years.
The Journal of ThoracicPatency rates were 100% at 2 years. Huang and colleagues9
implanted Nitinol stents into the external iliac arteries of
dogs and pigs for 8 months and observed the formation of a
smooth neointima with the absence of any inflammatory cell
infiltration or foreign giant cell reaction. After these results,
it appears that the observed early stenosis of the bypass
grafts is not due to the application of Nitinol. However,
long-term patency rates of the Symmetry Nitinol connectors
are currently unknown, and angiographic long-term fol-
low-up studies should be performed.
We have used the connector mainly in patients with
severely calcified ascending aortas to prevent embolization
by avoiding side clamping. These patients supposedly ben-
efit most from the device. Considering the high costs per
connector, we have restricted the application to patients
with diseased aortas.
A major concern regarding stenosis of the Symmetry
connector is the potential angulation and kinking of the vein
graft distally to the device. In all cases special attention was
paid to the accurate placement and length of the graft. Thus
no immediate intraoperative angulation or kinking of the
vein grafts was observed. In addition, all surgeons had to
pass a short learning curve for managing the fast and reli-
able handling of the new connector device, but we did not
observe any accumulation of early restenosis during this
period. Furthermore, assessment of blood flow through the
bypass grafts was routinely performed to confirm appropri-
ate graft function. However, an impaired flow caused by
slight kinking or angulation of the vein distally to the
perpendicular implanted connector could result in an early
stenosis. A further aspect of concern appears to be the
transformation zone between the stiff vessel caused by the
intraluminal part of the device and the beginning of the
natural elastic part of the vessel wall at the end of the SACS.
At this level, turbulence might lead to the induction of early
proximal stenosis of the mechanically anastomosed vein
grafts.
Another proposed reason for the occurrence of early
stenosis might be the reduction of the effective orifice area
of the proximal anastomosis by the vein connector mecha-
nism. The Nitinol connector device invaginates the vein
walls through the aortotomy and therefore can potentially
cause a relative proximal stenosis intraoperatively.
In conclusion, the Symmetry connector system appears
to be a promising new device facilitating OPCAB surgery
without the need for side clamping the aorta. On the basis of
the presented observations, a routine application of the
SACS might not be advisable yet and might have to be
reserved for patients with a severely calcified aorta for
whom no other techniques are feasible. It has to be strongly
emphasized that particular care has to be taken concerning
appropriate placement of the connector to avoid any kinking
of the vein graft. Future improvements of the device should
and Cardiovascular Surgery ● Volume 127, Number 5 1425
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would avoid any potential graft kinking and toward the
elimination of any nonphysiologic intravascular surfaces.
Furthermore, early angiographic follow-up studies appear to
be clearly indicated for evaluation of the performance of
this new device.
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